1. miR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression
    Fang Ma et al, 2017 CrossRef
  2. miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.
    Ying Wu et al, 2016, Oncol Lett CrossRef
  3. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer
    Wenjun Zhang et al, 2018, European Journal of Pharmacology CrossRef
  4. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma
    Christiane Matuszcak et al, 2018, Surgical Oncology CrossRef
  5. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer
    Xu Chen et al, 2018, J Exp Clin Cancer Res CrossRef
  6. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
    Bin Song et al, 2018, Biol Res CrossRef
  7. Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma.
    A K Eichelmann et al, 2018, Sci Rep CrossRef
  8. In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer
    Claudia Mazo et al, 2018, Cancers CrossRef
  9. The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis.
    Mahsa Javadian et al, 2019, J Cell Physiol CrossRef
  10. Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells
    Ilda Theka et al, 2019, Sci Rep CrossRef
  11. Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer
    Nijiro Nohata et al, 2017, J Hum Genet CrossRef
  12. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
    Jéssica Zani Lacerda et al, 2019, Microrna CrossRef
  13. MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM
    Ming-Jenn Chen et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  14. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation
    Takahiro Shimizu et al, 2019, Cellular and Molecular Gastroenterology and Hepatology CrossRef
  15. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.
    Yong Chen et al, 2017, PLoS One CrossRef
  16. The Regulatory Role of MicroRNAs in Breast Cancer
    Hui-Yi Loh et al, 2019, IJMS CrossRef
  17. Exosomes Derived From MicroRNA-148b-3p-Overexpressing Human Umbilical Cord Mesenchymal Stem Cells Restrain Breast Cancer Progression
    Lei Yuan et al, 2019, Front. Oncol. CrossRef
  18. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
    Maryam Abolghasemi et al, 2019, J Cell Physiol CrossRef
  19. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
    Dharambir Kashyap et al, 2020, Life Sciences CrossRef
  20. Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
    Kirti S. Prabhu et al, 2020, Cancers CrossRef
  21. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR‐148a‐3p/WNT1 pathway
    Li Han et al, 2020, J Cell Mol Med CrossRef
  22. microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
    Marta Gomarasca et al, 2020, IJMS CrossRef
  23. MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.
    Jianwei Liu et al, 2018, Exp Ther Med CrossRef
  24. MicroRNA-24-3p regulates Hodgkin's lymphoma cell proliferation, migration and invasion by targeting DEDD.
    Jing Wang et al, 2019, Oncol Lett CrossRef
  25. Role of microRNA in forming breast carcinoma
    Momi Saikia et al, 2020, Life Sciences CrossRef
  26. Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
    Ishita Gupta et al, 2020, IJMS CrossRef
  27. The role of CAF derived exosomal MicroRNAs in the tumour microenvironment of melanoma
    M. Shelton et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  28. Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
    Wenxia Zhao et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  29. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
    Amal Qattan, 2020, IJMS CrossRef
  30. GPER1 and microRNA: Two Players in Breast Cancer Progression
    Adele Vivacqua, 2020, IJMS CrossRef
  31. STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells
    Shunli Pan et al, 2021, Cell Death Dis CrossRef
  32. miRNAs: Critical mediators of breast cancer metastatic programming.
    Madhumathy G Nair et al, 2021, Exp Cell Res CrossRef
  33. miRNA-mediated alteration of sulfatase modifying factor 1 expression using self-assembled branched DNA nanostructures
    Kanchan Kumari et al, 2021, RSC Adv. CrossRef
  34. MicroRNA Regulation of Breast Cancer Stemness
    Brock Humphries et al, 2021, IJMS CrossRef
  35. Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives
    Li-Bo Tang et al, 2021, Biology CrossRef
  36. Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation
    Sho Okumura et al, 2021, Sci Rep CrossRef
  37. miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients
    Nesreen G. Elhelbawy et al, 2021, Biochemistry and Biophysics Reports CrossRef
  38. Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature
    Chrystel Isca et al, 2021, Cancers CrossRef
  39. Suppressive Role of MicroRNA-148a in Cell Proliferation and Invasion in Ovarian Cancer Through Targeting Transforming Growth Factor-β-Induced 2
    Min Zhao et al, 2016, oncol res CrossRef
  40. MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer
    Adilijiang Maimaitiming et al, 2020, oncol res CrossRef
  41. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA / mRNA expression analysis
    Snehal Nirgude et al, 2022, Cancer Reports CrossRef
  42. Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth
    Margherita Zamberlan et al, 2022, J Exp Clin Cancer Res CrossRef
  43. Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs
    Xinzhi Yang et al, 2022, Life Sciences CrossRef
  44. Could inhibition of metalloproteinases be used to block the process of metastasis?
    Jesús Alba et al, 2022, Cell Biochemistry & Function CrossRef
  45. HDAC2- and EZH2-Mediated Histone Modifications Induce PDK1 Expression through miR-148a Downregulation in Breast Cancer Progression and Adriamycin Resistance.
    Yunxia Xie et al, 2022, Cancers (Basel) CrossRef
  46. Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability
    Oana Baldasici et al, 2022, IJMS CrossRef
  47. A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma
    Zhuangzhuang Lu et al, 2022, BioMed Research International CrossRef
  48. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
    Ahmed Ismail et al, 2022, International Journal of Biological Macromolecules CrossRef
  49. Inhibition of WNT Signaling by Conjugated microRNA nano-carriers: A New Therapeutic Approach for Treating Triple-negative Breast Cancer A Perspective Review
    Manosi Banerjee et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
  50. Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
    Mehrdad Hashemi et al, 2023, International Journal of Biological Macromolecules CrossRef
  51. Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs
    Spencer Arnesen et al, 2023 CrossRef
  52. MicroRNAs: The key players regulating the crosstalk between Hippo and Wnt/β-catenin pathways in breast cancer
    Rinki Doloi et al, 2023, Life Sciences CrossRef
  53. Chonggu Granules Improve Cartilage Matrix Metabolism in Knee Osteoarthritis via the miR-148a-3p/Wnt/β-Catenin Pathway
    Lili Cheng et al, 2023, JIR CrossRef
  54. Unraveling the Potential of CSCs-miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
    Raquel Nogueras Pérez et al, 2023, IJMS CrossRef
  55. miRNA on the Battlefield of Cancer: Significance in Cancer Stem Cells, WNT Pathway, and Treatment
    Lekha Bhagtaney et al, 2024, Cancers CrossRef
  56. Functions of Differentially Regulated miRNAs in Breast Cancer Progression: Potential Markers for Early Detection and Candidates for Therapy
    Kumar Subramanian et al, 2024, Biomedicines CrossRef
  57. Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies
    Aimi Syamima Abdul Manap et al, 2024, Front. Cell Dev. Biol. CrossRef
  58. Breast Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Findings of Idiopathic Granulomatous Mastitis: A Retrospective Single-Center Clinical Study
    Filiz Taşçı et al, 2024, hamidiyemedj CrossRef
  59. Role of MicroRNA Modulated Wnt Pathway in Breast Cancer and Its Therapeutic Use
    null Shrila Banerjee et al, 2024, Cytol. Genet. CrossRef
  60. Non-Coding RNAs: Key Regulators of CDK and Wnt/β-catenin signaling in Cancer
    Mohammad Arshad Javed Shaikh et al, 2024, Pathology - Research and Practice CrossRef